papers/reddyGeneticFunctionalDrivers2017.md
... ...
@@ -92,7 +92,6 @@ All other DLBCL studies, DLBCL Tier 2, 145
92 92
|[NFKB2](../NFKB2)|2 |★ ★ ☆ ☆ ☆|**Fail**|
93 93
|[PHF6](../PHF6)|2 |★ ★ ☆ ☆ ☆|**Fail**|
94 94
|[PIK3CD](../PIK3CD)|2 |★ ★ ☆ ☆ ☆|**Fail**|
95
-
96 95
|[PTPRK](../PTPRK)|2 |★ ★ ☆ ☆ ☆|**Fail**|
97 96
|[RARA](../RARA)|2 |★ ☆ ☆ ☆ ☆|**Fail**|
98 97
|[ARID1B](../ARID1B)|2 |★ ★ ☆ ☆ ☆|**Fail**|
papers/reddyGeneticFunctionalDrivers2017_tmp.html
... ...
@@ -725,17 +725,62 @@ All other DLBCL studies, DLBCL Tier 2, 145
725 725
<td style="text-align:center">★ ★ ☆ ☆ ☆</td>
726 726
<td style="text-align:center"><strong>Fail</strong></td>
727 727
</tr>
728
+<tr>
729
+<td style="text-align:left"><a href="../PTPRK">PTPRK</a></td>
730
+<td style="text-align:center">2</td>
731
+<td style="text-align:center">★ ★ ☆ ☆ ☆</td>
732
+<td style="text-align:center"><strong>Fail</strong></td>
733
+</tr>
734
+<tr>
735
+<td style="text-align:left"><a href="../RARA">RARA</a></td>
736
+<td style="text-align:center">2</td>
737
+<td style="text-align:center">★ ☆ ☆ ☆ ☆</td>
738
+<td style="text-align:center"><strong>Fail</strong></td>
739
+</tr>
740
+<tr>
741
+<td style="text-align:left"><a href="../ARID1B">ARID1B</a></td>
742
+<td style="text-align:center">2</td>
743
+<td style="text-align:center">★ ★ ☆ ☆ ☆</td>
744
+<td style="text-align:center"><strong>Fail</strong></td>
745
+</tr>
746
+<tr>
747
+<td style="text-align:left"><a href="../RUNX1">RUNX1</a></td>
748
+<td style="text-align:center">2</td>
749
+<td style="text-align:center">★ ★ ☆ ☆ ☆</td>
750
+<td style="text-align:center"><strong>Fail</strong></td>
751
+</tr>
752
+<tr>
753
+<td style="text-align:left"><a href="../CBLB">CBLB</a></td>
754
+<td style="text-align:center">2</td>
755
+<td style="text-align:center">★ ★ ☆ ☆ ☆</td>
756
+<td style="text-align:center"><strong>Fail</strong></td>
757
+</tr>
758
+<tr>
759
+<td style="text-align:left"><a href="../SYK">SYK</a></td>
760
+<td style="text-align:center">2</td>
761
+<td style="text-align:center">★ ★ ☆ ☆ ☆</td>
762
+<td style="text-align:center"><strong>Fail</strong></td>
763
+</tr>
764
+<tr>
765
+<td style="text-align:left"><a href="../WAC">WAC</a></td>
766
+<td style="text-align:center">2</td>
767
+<td style="text-align:center">★ ★ ☆ ☆ ☆</td>
768
+<td style="text-align:center"><strong>Fail</strong></td>
769
+</tr>
770
+<tr>
771
+<td style="text-align:left"><a href="../ZBTB7A">ZBTB7A</a></td>
772
+<td style="text-align:center">2</td>
773
+<td style="text-align:center">★ ☆ ☆ ☆ ☆</td>
774
+<td style="text-align:center"><strong>Fail</strong></td>
775
+</tr>
776
+<tr>
777
+<td style="text-align:left"><a href="../ZFAT">ZFAT</a></td>
778
+<td style="text-align:center">2</td>
779
+<td style="text-align:center">★ ★ ☆ ☆ ☆</td>
780
+<td style="text-align:center"><strong>Fail</strong></td>
781
+</tr>
728 782
</tbody>
729 783
</table>
730
-<p>|<a href="../PTPRK">PTPRK</a>|2 |★ ★ ☆ ☆ ☆|<strong>Fail</strong>|
731
-|<a href="../RARA">RARA</a>|2 |★ ☆ ☆ ☆ ☆|<strong>Fail</strong>|
732
-|<a href="../ARID1B">ARID1B</a>|2 |★ ★ ☆ ☆ ☆|<strong>Fail</strong>|
733
-|<a href="../RUNX1">RUNX1</a>|2 |★ ★ ☆ ☆ ☆|<strong>Fail</strong>|
734
-|<a href="../CBLB">CBLB</a>|2 |★ ★ ☆ ☆ ☆|<strong>Fail</strong>|
735
-|<a href="../SYK">SYK</a>|2 |★ ★ ☆ ☆ ☆|<strong>Fail</strong>|
736
-|<a href="../WAC">WAC</a>|2 |★ ★ ☆ ☆ ☆|<strong>Fail</strong>|
737
-|<a href="../ZBTB7A">ZBTB7A</a>|2 |★ ☆ ☆ ☆ ☆|<strong>Fail</strong>|
738
-|<a href="../ZFAT">ZFAT</a>|2 |★ ★ ☆ ☆ ☆|<strong>Fail</strong>|</p>
739 784
<h2 id="see-also">See Also</h2>
740 785
<p>The primary data supporting each of the mutations reported in this study can be viewed in <a href="https://www.bcgsc.ca/downloads/morinlab/GAMBL/Reddy/igv_reports/">IGV reports</a> along with mutations unique to the GAMBL re-analysis.[@drevalRevisitingReddyDLBCL2023]</p>
741 786
<h1 id="references">References</h1>